<?xml version="1.0" encoding="UTF-8"?>
<p>There are clear indications that PeV-A circulates worldwide as it was detected in approximately 2% of specimens collected from children with a clinical suspicion of viral infections or as part of the national EV surveillance programs in Japan, Hong Kong, Denmark, Finland, the Netherlands, and the USA [
 <xref rid="B14-viruses-11-01062" ref-type="bibr">14</xref>,
 <xref rid="B15-viruses-11-01062" ref-type="bibr">15</xref>,
 <xref rid="B38-viruses-11-01062" ref-type="bibr">38</xref>,
 <xref rid="B39-viruses-11-01062" ref-type="bibr">39</xref>,
 <xref rid="B40-viruses-11-01062" ref-type="bibr">40</xref>,
 <xref rid="B41-viruses-11-01062" ref-type="bibr">41</xref>,
 <xref rid="B42-viruses-11-01062" ref-type="bibr">42</xref>,
 <xref rid="B43-viruses-11-01062" ref-type="bibr">43</xref>]. Furthermore, a remarkably high prevalence (23â€“57%) was recently demonstrated for PeV-A in children from Malawi [
 <xref rid="B33-viruses-11-01062" ref-type="bibr">33</xref>,
 <xref rid="B44-viruses-11-01062" ref-type="bibr">44</xref>].
</p>
